Quarterly report [Sections 13 or 15(d)]

Stock-Based Compensation - Liberty - Outstanding Awards (Details)

v3.25.3
Stock-Based Compensation - Liberty - Outstanding Awards (Details)
$ / shares in Units, $ in Millions
 9 Months Ended
Sep. 30, 2025
USD ($)
$ / shares
shares
Additional disclosures  
Total unrecognized compensation cost related to unvested equity awards | $ $ 36
Weighted average period of recognition related to unvested equity awards (in years) 3 years
Formula One Group | Series A  
Number of options  
Granted 0
Outstanding at end of period 0
Formula One Group | Series B  
Number of options  
Granted 0
Outstanding at end of period 0
Formula One Group | Series C  
Number of options  
Outstanding at beginning of period 4,138,000
Granted 214,000
Exercised (730,000)
Outstanding at end of period 3,622,000
Exercisable at end of period 3,221,000
WAEP  
Outstanding at beginning of period | $ / shares $ 39.53
Granted | $ / shares 94.11
Exercised | $ / shares 39.18
Outstanding at end of period | $ / shares 42.83
Exercisable at end of period | $ / shares $ 38.08
Additional disclosures  
Weighted average remaining life, outstanding 2 years 1 month 6 days
Weighted average remaining life, exercisable 1 year 7 months 6 days
Aggregate intrinsic value, outstanding | $ $ 223
Aggregate intrinsic value, exercisable | $ $ 214
Common stock reserved for issuance 3,600,000
Liberty Live Group | Series A  
Number of options  
Granted 0
Outstanding at end of period 0
Liberty Live Group | Series B  
Number of options  
Granted 0
Outstanding at end of period 0
Liberty Live Group | Series C  
Number of options  
Outstanding at beginning of period 1,230,000
Granted 24,000
Exercised (72,000)
Outstanding at end of period 1,182,000
Exercisable at end of period 1,102,000
WAEP  
Outstanding at beginning of period | $ / shares $ 42.68
Granted | $ / shares 76.45
Exercised | $ / shares 41.48
Outstanding at end of period | $ / shares 43.42
Exercisable at end of period | $ / shares $ 43.05
Additional disclosures  
Weighted average remaining life, outstanding 2 years 4 months 24 days
Weighted average remaining life, exercisable 2 years 2 months 12 days
Aggregate intrinsic value, outstanding | $ $ 63
Aggregate intrinsic value, exercisable | $ $ 59
Common stock reserved for issuance 1,200,000